The DOI matches its Crossref record; 69 of the 69 references it cites were found in a registry or an index.
Effects of surgical treatment of the metabolic syndrome on liver fibrosis and cirrhosis
Abstract
Background Both weight loss and gastrointestinal surgery for obesity can cause liver disease, making their role in the treatment of obesity-related liver disease controversial. Methods Six hundred eighty-nine severely obese women (n=551) and men (n=138), BMI=47+/-9 kg.m(-2) (mean+/-SD), without known liver disease, underwent biliopancreatic diversion (BPD) with liver biopsy. Fourteen patients (2%) had cryptogenic cirrhosis, 11 of whom underwent multiple repeat biopsies. After 38+/-18 kg weight loss, 104 of the 689 patients underwent routine second biopsies during reoperations 41+/-25 months after BPD. All biopsy specimens were graded for steatosis, fibrosis, and inflammation by a blinded hepatopathologist. Results All 689 patients lost weight accompanied by improvements in the metabolic syndrome. Among the 104 patients who underwent reoperation, severe fibrosis (grade 3-5) decreased in 28 whereas mild fibrosis (grade 1-2) appeared in 42. Increased fibrosis was related to low-normal serum albumin, uncontrolled diarrhea, low intake of alcohol, and menopausal status. Fibrosis and inflammation decreased over time (P<.01). The 11 patients with cirrhosis exhibited decreased fibrosis from a mean grade 5 to grade 3, as well as reduced inflammation, Mallory bodies, and glycogenated nuclei. Seven patients had disappearance and 2 regression of nodules and fibrous bridging. Conclusions The metabolic syndrome of obesity is a determinant of liver fibrosis and cirrhosis, treatable by substantial weight loss after malabsorptive surgery.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“However, one series found fibrosis scores worsened in 40% of patients (improved in 27%) despite reduced steatosis [53].”
From Impact of Bariatric Surgery and Endoscopic Therapies on Liver Health in Metabolic Dysfunction-Associated Steatotic Liver Disease: A Review (2025) · cites this paper as [53]
In the citing paper
“However, its complexity, risks of malabsorption and its nutritional consequences, and the rare potential for accelerated liver fibrosis limit widespread adoption [53,58,59,60].”
From Impact of Bariatric Surgery and Endoscopic Therapies on Liver Health in Metabolic Dysfunction-Associated Steatotic Liver Disease: A Review (2025) · cites this paper as [53]
In the citing paper
“Accordingly, BPD-DS leads to resolution of steatohepatitis in a majority of patients and can even regress advanced disease [53,54,55].”
From Impact of Bariatric Surgery and Endoscopic Therapies on Liver Health in Metabolic Dysfunction-Associated Steatotic Liver Disease: A Review (2025) · cites this paper as [53]
Citations
Cites
Ford, E. S., Giles, W. H., & Dietz, W. H. (2002) · JAMA · doi:10.1001/jama.287.3.356 · Cited by 6,698
Nonalcoholic Fatty Liver Disease
Angulo, P. (2002) · New England Journal of Medicine · doi:10.1056/nejmra011775 · Cited by 5,228
Steatohepatitis: A tale of two “hits”?
Day, C. P., & James, O. F. W. (1998) · Gastroenterology · doi:10.1016/s0016-5085(98)70599-2 · Cited by 4,285
Nonalcoholic fatty liver disease: a spectrum of clinical and pathological severity.
MATTEONI, C., YOUNOSSI, Z., GRAMLICH, T., BOPARAI, N., LIU, Y., & MCCULLOUGH, A. (1999) · Gastroenterology · doi:10.1016/s0016-5085(99)70506-8 · Cited by 3,345
The Hypothalamic–Pituitary–Adrenal Axis and Immune-Mediated Inflammation
Chrousos, G. P. (1995) · New England Journal of Medicine · doi:10.1056/nejm199505183322008 · Cited by 2,579
Elevated C-reactive protein levels in overweight and obese adults
Visser, M. (1999) · JAMA · doi:10.1001/jama.282.22.2131 · Cited by 2,494
Nonalcoholic steatohepatitis: association of insulin resistance and mitochondrial abnormalities
Sanyal, A. J., Campbell–Sargent, C., Mirshahi, F., Rizzo, W. B., Contos, M. J., Sterling, R. K., Luketic, V. A., Shiffman, M. L., & Clore, J. N. (2001) · Gastroenterology · doi:10.1053/gast.2001.23256 · Cited by 2,078
Molecular Regulation of Hepatic Fibrosis, an Integrated Cellular Response to Tissue Injury
Friedman, S. L. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.4.2247 · Cited by 2,067
Bravo, A. A., Sheth, S. G., & Chopra, S. (2001) · New England Journal of Medicine · doi:10.1056/nejm200102153440706 · Cited by 2,047
Prevalence of impaired glucose tolerance among children and adolescents with marked obesity
Sinha, R., Fisch, G., Teague, B., Tamborlane, W. V., Banyas, B., Allen, K., Savoye, M., Rieger, V., Taksali, S., Barbetta, G., et al. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa012578 · Cited by 1,709
Research works printed but not linked: 1
- Bowker, 1948, Bowker's test of symmetry, J Am Statistical Assoc, 43, 572, 10.2307/2280710 · DOI
Cited by
Sorted by citations
Items 101–200 of 321
de Ridder, R. J. J., Schoon, E. J., Smulders, J. F., van Hout, G. C. M., Stockbrügger, R. W., & Koek, G. H. (2007) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2007.03483.x · Cited by 51
Fibrosis and Cirrhosis Reversibility: Clinical Features and Implications
Pinzani, M., & Vizzutti, F. (2008) · Clinics in Liver Disease · doi:10.1016/j.cld.2008.07.006 · Cited by 51
Novel treatment modalities for nonalcoholic steatohepatitis
Satapathy, S. K., & Sanyal, A. J. (2010) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2010.08.003 · Cited by 49
Current and Emerging Therapies in Nonalcoholic Fatty Liver Disease
Kashi, M., Torres, D., & Harrison, S. D. (2008) · Seminars in liver disease (Print) · doi:10.1055/s-0028-1091984 · Cited by 54
Preoperative Assessment and Perioperative Care of Patients Undergoing Bariatric Surgery
Kuruba, R., Koche, L. S., & Murr, M. M. (2007) · Medical Clinics of North America · doi:10.1016/j.mcna.2007.01.010 · Cited by 49
Praveenraj, P., Gomes, R. M., Kumar, S. S., Karthikeyan, P., Annapoorni, S., Parthasarathi, R., Senthilnathan, P., Rajapandian, S., & Palanivelu, C. (2015) · Obesity Surgery · doi:10.1007/s11695-015-1655-1 · Cited by 49
Peng, Y., Rideout, D. A., Rakita, S., Gower, W. R., You, M., & Murr, M. M. (2009) · Journal of Gastrointestinal Surgery · doi:10.1007/s11605-009-1102-5 · Cited by 47
de Oliveira, C. P. M. S., Faintuch, J., Rascovski, A., Junior, C. K. F., Bastos, M. D. S. C. B. D. O., Matsuda, M., Nina, B. I. D., Yahnosi, K., Abdalla, D. S. P., Paranaguá‐Vezozzo, D. C., et al. (2005) · Obesity Surgery · doi:10.1381/0960892053723493 · Cited by 47
Popov, V., & Lim, J. K. (2015) · Journal of Clinical and Translational Hepatology · doi:10.14218/jcth.2015.00019 · Cited by 45
Evidence-based medicine reports on obesity surgery: a critique
Sugerman, H. J., & Kral, J. G. (2005) · International Journal of Obesity · doi:10.1038/sj.ijo.0802930 · Cited by 45
Self-citationTreatment regimens for non-alcoholic fatty liver disease
Lam, B. P., & Younossi, Z. M. (2009) · Annals of Hepatology · doi:10.1016/s1665-2681(19)31827-7 · Cited by 45
Bariatric Surgery in Cirrhotic Patients: Is It Safe?
Younus, H., Sharma, A., Miquel, R., Quaglia, A., Kanchustambam, S. R., Carswell, K. A., & Patel, A. G. (2019) · Obesity Surgery · doi:10.1007/s11695-019-04214-7 · Cited by 45
Chauhan, M., Singh, K., & Thuluvath, P. J. (2022) · Digestive Diseases and Sciences · doi:10.1007/s10620-021-07317-3 · Cited by 48
Sanderson, S. O., & Smyrk, T. C. (2005) · American Journal of Clinical Pathology · doi:10.1309/1px2-lmpq-uh1e-e12u · Cited by 45
Dolce, C. J., Russo, M. W., Keller, J. E., Buckingham, J., Norton, H. J., Heniford, B. T., Gersin, K. S., & Kuwada, T. S. (2009) · Surgery for Obesity and Related Diseases · doi:10.1016/j.soard.2008.12.008 · Cited by 44
Outcomes of Bariatric Surgery in Patients with Cirrhosis
Miñambres, I., Rubio, M. Á., de Hollanda, A., Lesmes, I. B., Vilarrasa, N., Pellitero, S., Bueno, M., Lecube, A., Marcuello, C., Goday, A., et al. (2018) · Obesity Surgery · doi:10.1007/s11695-018-3562-8 · Cited by 44
Eilenberg, M., Munda, P., Stift, J., Langer, F. B., Prager, G., Trauner, M., & Staufer, K. (2021) · HepatoBiliary Surgery and Nutrition · doi:10.21037/hbsn-20-787 · Cited by 42
The Role of Liver Biopsy to Assess Non-Alcoholic Fatty Liver Disease
Kobyliak, N. M., & Abenavoli, L. (2015) · Reviews on Recent Clinical Trials · doi:10.2174/1574887109666141216102231 · Cited by 43
Metabolic syndrome after liver transplantation: Preventable illness or common consequence?
Kallwitz, E. R. (2012) · World Journal of Gastroenterology · doi:10.3748/wjg.v18.i28.3627 · Cited by 43
Molecular and immunohistochemical effects of metformin in a rat model of type 2 diabetes mellitus
Ismail, T. A., Soliman, M. M., & NASSAN, M. A. (2015) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2015.2354 · Cited by 43
Salman, M. A., Mikhail, H. M. S., Nafea, M. A., Sultan, A. A. E. A., Elshafey, H. E., Tourky, M. S., Awad, A., Abouelregal, T. E., Ahmed, R. A., Ashoush, O. A., et al. (2020) · Surgical Endoscopy · doi:10.1007/s00464-020-07498-4 · Cited by 42
Agarwal, L., Aggarwal, S., Shalimar, S., Yadav, R., DATTAGUPTA, S., Garg, H., & Agarwal, S. (2020) · Obesity Surgery · doi:10.1007/s11695-020-04977-4 · Cited by 42
Pharmacological and non-pharmacological treatment of non-alcoholic fatty liver disease
Kaser, S., Ebenbichler, C. F., & Tilg, H. (2010) · International Journal of Clinical Practice · doi:10.1111/j.1742-1241.2009.02327.x · Cited by 42
Surgical Treatment for Obesity and Its Impact on Non-alcoholic Steatohepatitis
Dixon, J. B. (2007) · Clinics in Liver Disease · doi:10.1016/j.cld.2007.02.005 · Cited by 42
Marceau, P., Biron, S., Marceau, S., Hould, F., Lebel, S., Lescelleur, O., Biertho, L. D., & Kral, J. G. (2014) · Obesity Surgery · doi:10.1007/s11695-014-1284-0 · Cited by 41
Self-citationNovel Pharmacotherapy Options for NASH
Ratziu, V. (2016) · Digestive Diseases and Sciences · doi:10.1007/s10620-016-4128-z · Cited by 43
Wolter, S., Duprée, A., Coelius, C., Gammal, A. T. E., Kluwe, J., Sauer, N., & Mann, O. (2016) · Obesity Surgery · doi:10.1007/s11695-016-2253-6 · Cited by 41
Hemojuvelin: A New Link Between Obesity and Iron Homeostasis
Luciani, N., Brasse‐Lagnel, C., Poli, M., Anty, R., Lesueur, C., Cormont, M., Laquerrière, A., Folope, V., MARCHAND‐BRUSTEL, Y. L., Gugenheim, J., et al. (2011) · Obesity · doi:10.1038/oby.2011.12 · Cited by 43
Agarwal, L., Sahu, A. K., Baksi, A., Agarwal, A., & Aggarwal, S. (2020) · Surgery for Obesity and Related Diseases · doi:10.1016/j.soard.2020.11.004 · Cited by 39
Reversal of hepatic fibrosis: pathophysiological basis of antifibrotic therapies
Ismail, M. H., & Pinzani, M. (2011) · Hepatic Medicine Evidence and Research · doi:10.2147/hmer.s9051 · Cited by 38
Recommendations for Management and Treatment of Nonalcoholic Steatohepatitis
Ratziu, V., Ghabril, M., Romero‐Gómez, M., & Svegliati‐Baroni, G. (2018) · Transplantation · doi:10.1097/tp.0000000000002483 · Cited by 40
Salman, A., Sultan, A. A. E. A., Abdallah, A., Abdelsalam, A., Mikhail, H. M. S., Tourky, M. S., Omar, M. G., Youssef, A., Ahmed, R. A., Elkassar, H., et al. (2020) · Journal of Gastroenterology and Hepatology · doi:10.1111/jgh.15029 · Cited by 38
Approach to the Diagnosis and Treatment of Nonalcoholic Fatty Liver Disease
Ong, J. P., & Younossi, Z. M. (2005) · Clinics in Liver Disease · doi:10.1016/j.cld.2005.07.002 · Cited by 37
Yurcisin, B. M., Gaddor, M. M., & DeMaria, E. J. (2009) · Clinics in Chest Medicine · doi:10.1016/j.ccm.2009.05.013 · Cited by 38
Fiel, M. I., Wu, H., Iyer, K. R., Rodriguez‐Laiz, G., & Schiano, T. D. (2009) · Journal of Gastrointestinal Surgery · doi:10.1007/s11605-009-0914-7 · Cited by 36
Management of Nonalcoholic Steatohepatitis
Mahady, S. E., & George, J. (2012) · Clinics in Liver Disease · doi:10.1016/j.cld.2012.05.003 · Cited by 36
Ilan, Y. (2016) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.13833 · Cited by 36
Effect of pronounced weight loss on visceral fat, liver steatosis and adiponectin isoforms
Engl, J., Sturm, W., Sandhofer, A., Kaser, S., Tschoner, A., Tatarczyk, T., Weiss, H., Tilg, H., Patsch, J. R., & Ebenbichler, C. F. (2008) · European Journal of Clinical Investigation · doi:10.1111/j.1365-2362.2008.01929.x · Cited by 35
Managing diabetes in patients with chronic liver disease
Khan, R., Foster, G. R., & Chowdhury, T. A. (2012) · Postgraduate Medicine · doi:10.3810/pgm.2012.07.2574 · Cited by 34
TINIAKOS, D. G., Anstee, Q. M., & Burt, A. D. (2017) · Elsevier eBooks · doi:10.1016/b978-0-7020-6697-9.00005-4 · Cited by 35
Nonalcoholic fatty liver disease and obesity.
Salgado, W., dos Santos, J. S., Sankarankutty, A., & Silva, O. D. C. E. (2006) · Acta Cirurgica Brasileira · doi:10.1590/s0102-86502006000700017 · Cited by 16
Evolving trends in nonalcoholic fatty liver disease
Delgado, J. (2008) · European Journal of Internal Medicine · doi:10.1016/j.ejim.2007.02.034 · Cited by 31
Non‐Alcoholic Fatty Liver and Non‐Alcoholic Steatohepatitis
Farrell, G. C. (2007) · doi:10.1002/9780470691861.ch13 · Cited by 31
Are, V. S., Knapp, S. M., Banerjee, A., Shamseddeen, H., Ghabril, M., Orman, E. S., Patidar, K. R., Chalasani, N., & Desai, A. P. (2020) · The American Journal of Gastroenterology · doi:10.14309/ajg.0000000000000911 · Cited by 30
Bai, J., Jia, Z., Chen, Y., Li, Y., Zheng, S., & Duan, Z. (2022) · World Journal of Surgery · doi:10.1007/s00268-021-06382-z · Cited by 30
Functional Liver Recovery After Bariatric Surgery—a Prospective Cohort Study with the LiMAx Test
Alizai, P. H., Wendl, J., Roeth, A. A., Klink, C., Luedde, T., Steinhoff, I., Neumann, U. P., Schmeding, M., & Ulmer, T. F. (2015) · Obesity Surgery · doi:10.1007/s11695-015-1664-0 · Cited by 30
Current Treatment of Nonalcoholic Fatty Liver Disease/Nonalcoholic Steatohepatitis
Hung, C. K., & Bodenheimer, H. C. (2017) · Clinics in Liver Disease · doi:10.1016/j.cld.2017.08.012 · Cited by 30
Lavín-Alconero, L., Fernández-Lanas, T., Iruzubieta, P., Arias, M., Rodríguez-Duque, J. C., Rivas, C., Cagigal, M. L., Montalbán, C., Useros, A. L., Álvarez-Cancelo, A., et al. (2021) · Trials · doi:10.1186/s13063-021-05695-7 · Cited by 29
Nonalcoholic fatty liver disease and bariatric surgery
Stephen, S., Baranova, A. V., & Younossi, Z. M. (2012) · Expert Review of Gastroenterology & Hepatology · doi:10.1586/egh.11.97 · Cited by 29
Nonalcoholic fatty liver disease in severely obese individuals: The influence of bariatric surgery
de Andrade, A. R. C. F., Cotrim, H. P., Alves, E. S., Soares, D. A., Rocha, R., Almeida, A. D. M., Almeida, C. G., & de Freitas, L. A. (2008) · Annals of Hepatology · doi:10.1016/s1665-2681(19)31838-1 · Cited by 29
The Duodenal Switch as an Increasing and Highly Effective Operation for Morbid Obesity
Rabkin, R. A. (2004) · Obesity Surgery · doi:10.1381/0960892041590863 · Cited by 29
Russo, M. F., Lembo, E., Mari, A., Angelini, G., Verrastro, O., Nanni, G., Pompili, M., Raffaelli, M., Vecchio, F. M., Bornstein, S. R., et al. (2021) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgaa892 · Cited by 28
The role of bariatric surgery in nonalcoholic fatty liver disease and nonalcoholic steatohepatitis
Shouhed, D., Steggerda, J. A., Burch, M. A., & Noureddin, M. (2017) · Expert Review of Gastroenterology & Hepatology · doi:10.1080/17474124.2017.1355731 · Cited by 28
Update on bariatric surgery in adolescence
Thakkar, R. K., & Michalsky, M. P. (2015) · Current Opinion in Pediatrics · doi:10.1097/mop.0000000000000223 · Cited by 27
Brunt, E. M., Neuschwander‐Tetri, B. A., & Burt, A. D. (2011) · Elsevier eBooks · doi:10.1016/b978-0-7020-3398-8.00006-4 · Cited by 27
The impact of bariatric surgery on nonalcoholic fatty liver disease
de Freitas, A. C. D., Campos, A. C., & Coelho, J. C. (2008) · Current opinion in clinical nutrition and metabolic care · doi:10.1097/mco.0b013e3282fbd33f · Cited by 23
Bariatric surgery and nonalcoholic fatty liver disease
Bower, G., Athanasiou, T., Isla, A., Harling, L., Li, J. V., Holmes, E. C., Efthimiou, E., Darzi, A. W., & Ashrafian, H. (2015) · European Journal of Gastroenterology & Hepatology · doi:10.1097/meg.0000000000000375 · Cited by 27
Nonalcoholic Fatty Liver Disease and Type 2 Diabetes Mellitus: The Hidden Epidemic
Ismail, M. H. (2011) · The American Journal of the Medical Sciences · doi:10.1097/maj.0b013e3182018598 · Cited by 26
Laparoscopic Adjustable Gastric Banding In Patients with Unexpected Cirrhosis: Safety and Outcomes
Woodford, R. M., Burton, P. R., O’Brien, P. E., Laurie, C., & Brown, W. A. (2015) · Obesity Surgery · doi:10.1007/s11695-015-1623-9 · Cited by 26
Han, H., Hu, C.-X., Wang, L., Zhang, G., Liu, S., Li, F., Sun, D., & Hu, S. (2014) · Obesity Surgery · doi:10.1007/s11695-014-1308-9 · Cited by 25
Treating morbid obesity in cirrhosis: A quest of holy grail
Kumar, N. (2015) · World Journal of Hepatology · doi:10.4254/wjh.v7.i28.2819 · Cited by 25
Nutrition, Diet Therapy, and the Liver
Preedy, V. R., Lakshman, M., Srirajaskanthan, R., & WATSON, R. R. (2009) · CRC Press eBooks · doi:10.1201/9781420085501 · Cited by 25
The Effects of Metabolic Surgery on Fatty Liver Disease and Nonalcoholic Steatohepatitis
Clanton, J., & Subichin, M. P. (2016) · Surgical Clinics of North America · doi:10.1016/j.suc.2016.03.008 · Cited by 27
Nonalcoholic fatty liver disease and bariatric surgery in adolescents
Holterman, A., Gurria, J. P., Tanpure, S., & DiSomma, N. M. (2013) · Seminars in Pediatric Surgery · doi:10.1053/j.sempedsurg.2013.10.016 · Cited by 23
Riley, P., O’Donohue, J., & Crook, M. A. (2007) · Journal of Clinical Pathology · doi:10.1136/jcp.2006.044891 · Cited by 23
Manco, M., Fernández‐Real, J. M., Vecchio, F. M., Vellone, V. G., Moreno‐Navarrete, J. M., Tondolo, V., Bottazzo, G., Nanni, G., & Mingrone, G. (2010) · Obesity Surgery · doi:10.1007/s11695-010-0129-8 · Cited by 22
Nonalcoholic Fatty Liver Disease
Ko, J. S. (2010) · Korean Journal of Gastroenterology · doi:10.4166/kjg.2010.56.1.6 · Cited by 24
Hansen, E. N., Torquati, A., & Abumrad, N. N. (2006) · Annual Review of Nutrition · doi:10.1146/annurev.nutr.26.061505.111242 · Cited by 22
OTT-FONTES, P. R., Neto, J. A. D., & Goldoni, M. B. (2020) · Revista do Colégio Brasileiro de Cirurgiões · doi:10.1590/0100-6991e-20202485 · Cited by 23
Watt, K. D. S. (2012) · Liver Transplantation · doi:10.1002/lt.23515 · Cited by 20
The Effect of Bariatric Surgery on the Spectrum of Fatty Liver Disease
Nostedt, J. J., Switzer, N. J., Gill, R. S., Dang, J. T., Birch, D. W., de Gara, C., Bailey, R. J., & Karmali, S. (2016) · Canadian Journal of Gastroenterology and Hepatology · doi:10.1155/2016/2059245 · Cited by 21
An adipocentric view of liver fibrosis and cirrhosis.
Chuang, J., Wang, P., & Tai, M.-H. (2004) · PubMed · Cited by 21
Impact of body weight, diet and lifestyle on nonalcoholic fatty liver disease
Cortez‐Pinto, H., & Machado, M. V. (2008) · Expert Review of Gastroenterology & Hepatology · doi:10.1586/17474124.2.2.217 · Cited by 21
The pathophysiology of severe obesity and the effects of surgically induced weight loss
Sugerman, H. J. (2005) · Surgery for Obesity and Related Diseases · doi:10.1016/j.soard.2005.01.004 · Cited by 21
Helling, T. S., Helzberg, J. H., Nachnani, J. S., & Gurram, K. C. (2008) · Surgery for Obesity and Related Diseases · doi:10.1016/j.soard.2007.11.007 · Cited by 20
Savari, F., & Mard, S. A. (2024) · Heliyon · doi:10.1016/j.heliyon.2024.e28468 · Cited by 21
Treatment of non-alcoholic fatty liver disease with focus on emerging drugs
Marchesini, G., Moscatiello, S., Agostini, F., Villanova, N., & Festi, D. (2011) · Expert Opinion on Emerging Drugs · doi:10.1517/14728214.2011.531700 · Cited by 20
Non-alcoholic steatohepatitis: An update in pathophysiology, diagnosis and therapy
Khedmat, H., & Taheri, S. (2011) · Hepatitis Monthly · Cited by 19
The effect of very low-calorie diets on renal and hepatic outcomes: a systematic review
Rolland, C., Mavroeidi, A., Johnston, K. L., & Broom, J. I. (2013) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmso.s51151 · Cited by 19
Quantification of Hepatic Fat and Iron with Magnetic Resonance Imaging
Wells, S. A. (2014) · Magnetic Resonance Imaging Clinics of North America · doi:10.1016/j.mric.2014.04.010 · Cited by 18
Therapies for non-alcoholic steatohepatitis
Dunn, W. (2017) · Liver Research · doi:10.1016/j.livres.2017.12.006 · Cited by 16
Liver Biopsy at the Time of Bariatric Surgery: A Benefit for Patients and the Medical Community
Verna, E. C. (2014) · Seminars in Liver Disease · doi:10.1055/s-0034-1371549 · Cited by 16
Morbid obesity, nonalcoholic fatty liver disease, and weight loss surgery†
Srivastava, S., Younossi, Z. M., Jaeschke, H., Mullen, K. D., & Moradpour, D. (2005) · Hepatology · doi:10.1002/hep.20782 · Cited by 16
Surgical Management of Obesity in Patients with Morbid Obesity and Nonalcoholic Fatty Liver Disease
Dixon, J. B. (2013) · Clinics in Liver Disease · doi:10.1016/j.cld.2013.09.011 · Cited by 15
Current Controversies in Metabolic Surgery for Nonalcoholic Fatty Liver Disease
Perysinakis, I., Pappis, H. C., & Margaris, E. (2019) · Obesity Surgery · doi:10.1007/s11695-019-03705-x · Cited by 15
Fazel, I., Pourshams, A., Merat, S., Hemayati, R., Sotoudeh, M., & Malekzadeh, R. (2007) · Journal of Gastrointestinal Surgery · doi:10.1007/s11605-007-0184-1 · Cited by 15
Nonalcoholic Fatty Liver Disease of Obesity
Sachdev, M., Riely, C., & Madan, A. (2006) · Obesity Surgery · doi:10.1381/096089206778870012 · Cited by 13
Taitano, A. A., Markow, M., Finan, J. E., Wheeler, D. E., Gonzalvo, J. P., & Murr, M. M. (2014) · Gastroenterology · doi:10.1016/s0016-5085(14)63678-7 · Cited by 15
Neuschwander‐Tetri, B. A. (2006) · Current Opinion in Endocrinology & Diabetes · doi:10.1097/01.med.0000216959.98385.02 · Cited by 15
Contribution of Bariatric Surgery to the Comprehension of Morbid Obesity
Marceau, P. (2005) · Obesity Surgery · doi:10.1381/0960892052993620 · Cited by 15
Self-citationResistin expression correlates with steatohepatitis in morbidly obese patients
Edwards, C. R., Hindle, A., Latham, P. S., Fu, S. W., & Brody, F. J. (2012) · Surgical Endoscopy · doi:10.1007/s00464-012-2603-y · Cited by 14
Is a bariatric procedure appropriate in patients with portal hypertension secondary to cirrhosis?
Sarr, M. G. (2006) · Surgery for Obesity and Related Diseases · doi:10.1016/j.soard.2006.01.012 · Cited by 14
Fibrosis Evaluation by Transient Elastography in Patients With Long-Term Sustained HCV Clearance
Calvaruso, V., Marco, V. D., Ferraro, D., Petta, S., Calì, A., Bavetta, M. G., Conte, E., & Almasio, P. L. (2013) · Hepatitis Monthly · doi:10.5812/hepatmon.7176 · Cited by 13
Nonalcoholic steatohepatitis: Pathogenesis and treatment
Park, S. H. (2008) · The Korean Journal of Hepatology · doi:10.3350/kjhep.2008.14.1.12 · Cited by 13
Tasabehji, D., Saleh, S., & Mokadem, M. (2025) · Journal of Clinical Medicine · doi:10.3390/jcm14124012 · Cited by 14
Surgical Management of Adolescent Obesity
Barnett, S. J. (2013) · Advances in Pediatrics · doi:10.1016/j.yapd.2013.04.014 · Cited by 12
Toman, D., Vavra, P., Jelínek, P., Ostruszka, P., Ihnat, P. M., Foltys, A., Pelikán, A., & Roman, J. (2021) · Biomedical Papers · doi:10.5507/bp.2021.021 · Cited by 13
Patient Selection and the Physiology of Gastrointestinal Antiobesity Operations
Näslund, E. B., & Kral, J. G. (2005) · Surgical Clinics of North America · doi:10.1016/j.suc.2005.03.006 · Cited by 12
Self-citationThe metabolic syndrome: Effects of a pronounced weight loss induced by bariatric surgery
Engl, J., Hanusch‐Enserer, U., Prager, R., Patsch, J. R., & Ebenbichler, C. F. (2005) · Wiener klinische Wochenschrift · doi:10.1007/s00508-005-0346-7 · Cited by 12
Surgical treatment of nonalcoholic fatty liver disease in severely obese patients
Holterman, A. L., Naalt, S. V., & Gurria, J. P. (2014) · Hepatic Medicine Evidence and Research · doi:10.2147/hmer.s64819 · Cited by 10
Metadata
- Authors
- Kral, J. G., Thung, S. N., Biron, S., Hould, F.-S., Lebel, S., Marceau, S., Simard, S., & Marceau, P.
- Affiliations
- State University of New York (US)
- Corresponding author
- Kral, John G
- Venue
- Surgery
- Publisher
- Elsevier BV
- Published
- 2004-01
- Volume
- 135
- Issue
- 1
- Pages
- 48-58
- ISSN
- 0039-6060 (ISSN-L)
- OpenAlex
- W2075060360
- Cited by
- 322
- References
- 69
- Citations by year
- 2026: 2 · 2025: 7 · 2024: 4 · 2023: 4 · 2022: 10 · 2021: 11 · 2020: 11 · 2019: 10 · 2018: 7 · 2017: 13 · 2016: 11 · 2015: 21 · 2014: 23 · 2013: 9 · 2012: 14
- FWCI
- 17.62
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Surgery (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Surgery › Bariatric Surgery and Outcomes
- Health Sciences › Medicine › Hepatology › Liver Disease Diagnosis and Treatment
- Health Sciences › Medicine › Hepatology › Liver Disease and Transplantation
- Keywords
- metabolic syndrome, obesity, liver fibrosis, liver cirrhosis, biliopancreatic diversion, bariatric surgery, weight loss, malabsorptive surgery, obesity-related liver disease, liver biopsy, steatosis, liver inflammation, serum albumin, menopause, fibrosis regression
- MeSH terms
- Adult, Biopsy, Fatty Liver, Female, Hepatitis, Humans, Liver, Liver Cirrhosis, Male, Middle Aged, Obesity, Morbid, Reoperation, Weight Loss, Biliopancreatic Diversion, Case-Control Studies, Single-Blind Method, Treatment Outcome, Metabolic Syndrome
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review